STAT+: Key senator opposes Democrats’ target for drug pricing savings

WASHINGTON — An influential Senate Democrat is pushing back against his party’s efforts to cut $600 billion out of the drug industry as part of a massive yet-to-be-unveiled spending package.

Since July, it’s been widely reported that Democrats are seeking around $600 billion in savings from the pharmaceutical industry to help pay for a number of policy priorities. But Sen. Tom Carper (D-Del.) told STAT in an interview Tuesday that he believed the goal of cutting $600 billion out of the drug industry was too ambitious.

Continue to STAT+ to read the full story…

STAT+: Key senator opposes Democrats’ target for drug pricing savings

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top